Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Belreca - Belgian Resources and Capital Company | BELR | Nov 21, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Nov 21, 2024 | 1.50 | 0.00 |
Belysse Group N.V. | BELYS | Nov 21, 2024 | 0.79 | -0.63 |
Biocartis Group NV | BCART | Nov 21, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Nov 21, 2024 | 0.01 | -1.61 |
Biotalys | BTLS | Nov 21, 2024 | 2.94 | -0.34 |
Boeing | BOEI | Nov 21, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Nov 21, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Nov 21, 2024 | 1.94 | +1.25 |
Brederode S.A. | BREB | Nov 21, 2024 | 105.00 | +0.96 |
Campine nv | CAMB | Nov 21, 2024 | 84.50 | -0.59 |
Candela Invest | CAND | Nov 21, 2024 | 1.20 | 0.00 |
Care Property Invest NV/SA | CPINV | Nov 21, 2024 | 12.08 | -0.17 |
Celyad Oncology SA | CYAD | Nov 21, 2024 | 0.65 | -5.25 |
Cenergy Holdings | CENER | Nov 21, 2024 | 8.31 | -0.95 |
Chevron | CHTEX | Nov 21, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Nov 21, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Nov 21, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Nov 21, 2024 | 54.90 | -1.26 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Nov 21, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Nov 21, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Nov 21, 2024 | 44.10 | -0.27 |
Compagnie du Bois Sauvage S.A. | COMB | Nov 21, 2024 | 215.00 | -1.38 |
Compagnie d`Entreprises CFE SA | CFEB | Nov 21, 2024 | 5.80 | +2.29 |
Connect Group | CONN | Nov 21, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Nov 21, 2024 | 0.01 | -1.92 |
Cumulex NV | CLEX | Nov 21, 2024 | 1.35 | 0.00 |
CURETIS | CURE | Nov 21, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Nov 21, 2024 | 2.42 | -0.82 |
Deme Group N.V. | DEME | Nov 21, 2024 | 143.20 | +1.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.